금융 뉴스 허브

Oil Price Forecasts Jump as Hormuz Disruption Drags On

Analysts have sharply raised their 2026 oil price forecasts as hopes fade for a quick normalization of shipping through the Strait of Hormuz, with a new Reuters poll putting Brent crude at an average ...

Midday Need to Know: Core PCE inflation rises, oil rebounds & more

A tough job market is pushing more young Americans to make a big bet: on themselves

There has been a rise in entrepreneurship among young Americans as the entry-level labor market has become tougher to join.

Don’t own bonds and be cautious with stocks

Balance sheets have become unbalanced and growth in turn may suffer the consequences

3 Reasons to Avoid COF and 1 Stock to Buy Instead

Although Capital One (currently trading at $197.72 per share) has gained 11% over the last six months, it has trailed the S&P 500’s 21.1% return during that period. This might have investors contempla ...

Micron Earnings Preview: The 5 key requirements for a successful Q4

Micron Technologies (MU) will release earnings after the close on Wednesday and the market views this release as the next big puzzle in the ongoing AI stock rally.

UnitedHealth's seasonal pattern points to strong year-end window

Cigna Investor Day Spotlights Specialty Drugs

Cigna Group investors will be looking for more detail on the growth of its specialty pharmacy business under new CEO Brian Evanko.

Is CrowdStrike Stock Paying You Enough For The Swings?

You may own CrowdStrike (CRWD), a cybersecurity company whose shares rose 5.1% in five sessions as the S&P 500 fell 1.2%. You likely hold it beside an index fund, and your whole account swings more wh ...

Why Tesla’s $25 Billion Credit Line Is a High-Stakes Bet on AI and Robotaxis

Tesla is set to borrow a lot more money as it invests heavily in its AI ambitions. Tuesday, the EV maker entered into $25 billion in new credit facilities, including a $20 billion three-year delayed ...

Moderna and Fair Isaac: The Best and Worst S&P 500 Stocks for the Third Quarter

Moderna stock has rallied since the company unveiled clinical updates to its cancer vaccine in collaboration with Merck in late August.

3 Reasons to Sell FRPT and 1 Stock to Buy Instead

Freshpet currently trades at $57.15 per share and has shown little upside over the past six months, posting a middling return of 1%. The stock also fell short of the S&P 500’s 21.1% gain during that p ...